Jin Heiying, Yang Zhijian, Wang Jiangdong, Zhang Suying, Sun Yu, Ding Yijiang
National Center of Colorectal Surgery, The 3rd Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, 1 Jinling Road, Nanjing 210001, People's Republic of China.
Tumour Biol. 2011 Apr;32(2):391-7. doi: 10.1007/s13277-010-0132-7. Epub 2010 Nov 19.
The orthotopic transplantation model of human tumor has been demonstrated to be more patient-like animal tumor model. However, observations of tumor progression and metastasis are limited by the deep location of the colon or limited deep penetration ability of fluorescence through tissue. The purpose of this study is to establish a superficial orthotopic model to allow easier real-time visualization and more sensitive monitoring of fluorescent orthotopic colon tumor. Human colon cancer HT-29 cells were transduced with a pLPCX expression retroviral vector containing green fluorescent protein and neomycin resistance genes. For superficial orthotopic transplantation model, the cecum was identified and pulled out of the peritoneal cavity, the space between the cecum and peritoneum was sutured, the cecum was pulled to subcutaneous tissue, and incision was made on the cecal serosa followed by the implantation of a 1-mm tumor tissue to the cecum. For comparison, a conventional orthotopic transplantation model was established in a separate group of mice simultaneously. When tumor sizes reached 5 mm in diameter, half the mice in each model received 5-FU treatment. Primary tumor and metastases were monitored by fluorescent imaging or caliber measurement. Tumor fluorescence was observed as early as 3 days (median time of 4.7 ± 1.3 days) post-transplantation in the superficial orthotopic transplantation model, which was much earlier than 21 days (median time of 26.2 ± 9.9 days) in conventional orthotopic transplantation model. Although tumor growth of 5-FU-treated mice in conventional orthotopic model was lower than those of the untreated mice, the difference was not significant. However, in superficial orthotopic model, tumor growth was significantly inhibited in 5-FU-treated mice relative to the untreated mice. Fluorescence imaging showed similar metastasis incidence between the superficial and conventional orthotopic transplantation models. The fluorescent superficial orthotopic transplantation colon model allows easier real-time visualization and more sensitive monitoring of tumor growth as well as convenient repeated sampling. It is a valuable orthotopic implantation model for study of colon cancer and evaluation of new anti-cancer therapy.
人肿瘤原位移植模型已被证明是更接近患者的动物肿瘤模型。然而,肿瘤进展和转移的观察受到结肠位置较深或荧光穿透组织的深度有限的限制。本研究的目的是建立一种浅表原位模型,以便更轻松地进行实时可视化,并更敏感地监测荧光原位结肠肿瘤。用人结肠癌HT-29细胞转导含有绿色荧光蛋白和新霉素抗性基因的pLPCX表达逆转录病毒载体。对于浅表原位移植模型,识别盲肠并将其拉出腹腔,缝合盲肠与腹膜之间的间隙,将盲肠拉至皮下组织,在盲肠浆膜上切开,然后将1毫米的肿瘤组织植入盲肠。作为对照,同时在另一组小鼠中建立传统原位移植模型。当肿瘤大小达到直径5毫米时,每个模型中的一半小鼠接受5-氟尿嘧啶治疗。通过荧光成像或口径测量监测原发性肿瘤和转移灶。在浅表原位移植模型中,移植后最早3天(中位时间为4.7±1.3天)即可观察到肿瘤荧光,这比传统原位移植模型中的21天(中位时间为26.2±9.9天)要早得多。虽然传统原位模型中接受5-氟尿嘧啶治疗的小鼠的肿瘤生长低于未治疗的小鼠,但差异不显著。然而,在浅表原位模型中,与未治疗的小鼠相比,接受5-氟尿嘧啶治疗的小鼠的肿瘤生长受到显著抑制。荧光成像显示浅表和传统原位移植模型之间的转移发生率相似。荧光浅表原位移植结肠模型便于实时可视化和更敏感地监测肿瘤生长,以及方便地重复取样。它是研究结肠癌和评估新抗癌疗法的有价值的原位植入模型。